Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278.25 USD | +0.70% |
|
+0.39% | +18.25% |
P/E ratio (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
-137.51x | 642.01x | 3.2x | 15.15x | -510.27x | -266.46x | -.--% | 35.64B | ||
68.04x | 45.21x | 0.6x | 17.31x | 48.25x | 54.92x | 0.62% | 758B | ||
22.75x | 13.32x | 1.12x | 8.13x | 16.07x | 18x | 2.25% | 384B | ||
22.34x | 5.22x | -0.45x | 4.32x | 12.62x | 14.23x | 3.08% | 372B | ||
43.53x | 46.84x | 0.7x | 7.09x | 16.36x | 16.79x | 3.25% | 339B | ||
15.19x | 5.91x | 0.18x | 3.78x | 9.33x | 10.74x | 3.4% | 260B | ||
12.8x | 4.83x | 0x | 3.9x | 9.36x | 10.57x | 3.4% | 227B | ||
16.85x | 4.94x | 1.73x | 4.28x | 10.44x | 11.29x | 3.5% | 216B | ||
26.12x | 5.23x | 0.65x | 4.47x | 14.11x | 13.99x | 2.23% | 216B | ||
33.71x | 25.45x | -1.25x | 6.47x | 11.36x | 14.5x | 2.93% | 165B | ||
14.99x | 1.68x | 0.04x | 3.3x | 8.32x | 10.13x | 6.3% | 150B | ||
17.61x | 1.71x | 0.48x | 3.16x | 10.4x | 11.39x | 3.74% | 135B | ||
1013.22x | 6.54x | -10.36x | 5.02x | 13.4x | 17.25x | 3.08% | 124B | ||
-19.29x | 7.01x | 0.11x | 3.34x | 28.8x | 33.48x | 4.01% | 121B | ||
17.51x | 4.11x | -0.58x | 2.39x | 7.37x | 8.28x | 4.06% | 75.87B | ||
27.82x | 5.85x | 1.36x | 8.71x | 17.49x | 18.64x | 1.35% | 71.61B | ||
31.72x | 4.36x | 1.72x | 3.57x | 19.55x | 23.38x | 1.55% | 48.56B | ||
23.1x | 2.04x | 0.51x | 3.75x | 15.07x | 16.73x | 1.64% | 42.89B | ||
50.15x | 0.91x | -4.43x | 2.32x | 9.74x | 30.1x | 4.79% | 42.64B | ||
Average | 68.46x | 43.85x | -0.24x | 5.81x | -12.22x | 3.58x | percentage-no-prefix | 199.19B | |
Weighted average by Cap. | 62.44x | 24.40x | 0.05x | 7.61x | 15.37x | 20.46x | percentage-no-prefix |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
- Sector valuations

MarketScreener is also available in this country: United States.
Switch edition